Results 101 to 110 of about 7,095 (171)
Efficacy of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria among children aged 2-11 years in the Asante Akim North Municipality, Ghana: a single-arm open trial. [PDF]
Malar JHanson H, Marfo KS, Osei-Mensa J, Jaeger A, Sarpong N, Tsali DN, Martey A, Gyimah AK, Placca E, Oppong M, Foli G, Almoustapha NS, Amuasi J, May J, Maïga Ascofaré O. +14 moreeuropepmc +1 more sourceEfficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial. [PDF]
Lancet Infect DisKamya MR, Nankabirwa JI, Ebong C, Asua V, Kiggundu M, Orena S, Okitwi M, Tukwasibwe S, Agaba B, Kyabayinze D, Opigo J, Rutazana D, Binagwa B, Mugwanya E, Babirye S, Sebikaari G, Condo PM, Appiah G, Nsobya SL, Conrad MD, Rosenthal PJ, Moriarty LF, Yeka A. +22 moreeuropepmc +1 more sourceExtending seasonal malaria chemoprevention to older children: a non-inferiority randomized controlled trial of Dihydroartemisinin-piperaquine as a policy alternative in Mali. [PDF]
Lancet Reg Health AfrToure M, Keita S, Kane F, Sanogo D, Sanogo I, Keita M, Sissoko IM, Diallo M, Coulibaly H, Cisse B, Konate D, Guindo I, Malle MA, Tangara CO, Diawara SI, Cissoko M, Sanogo V, Kone A, Niare S, Maiga A, Sogoba N, Hansonn HH, Alifrangis M, Diakite M, Shaffer JG, Doumbia S. +25 moreeuropepmc +1 more sourceEstimating the changing prevalence of molecular markers of artemisinin partial resistance in Plasmodium falciparum malaria in Sub-Saharan Africa
Harrison LE, Golding N, Hao T, Botha I, van Wyk S, Mategula D, Dahal P, Raman J, Weiss DJ, Barnes KI, Guérin PJ, Flegg JA. +11 moreeuropepmc +1 more sourceEfficacy and Safety of Artesunate + Amodiaquine and Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Madagascar, 2020. [PDF]
Am J Trop Med HygHarimanana A, Randriamiarinjatovo DNAL, Rakotomanga TA, Irinantenaina J, Moriarty LF, Laird V, Patel D, Abdallah RA, Zhiyong Z, Svigel SS, Kapesa L, Razafindrakoto J, Ralinoro F, Rason MA, Andriamananjara MN, Razanatsiorimalala S, Razafinjato C, Randrianarivelojosia M. +17 moreeuropepmc +1 more sourceBorder Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]
Emerg Infect DisNiyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J. +25 moreeuropepmc +1 more sourceAmodiaquine as a filaricide.
The Journal of communicable diseases, 1983 R K, Chakravertty, R N, Rai, P, Chand, K P, Dey, C K, Rao +4 moreopenaire +1 more sourceGenomic Surveillance of malaria reveals localized sporadic emergence of artemisinin partial resistance and wide-spread sulfadoxine-pyrimethamine resistance in Ghana
Dorvi IN, Kudakpo AY, Mensah C, Ngoi JM, Bandoh K, Ayeke DY, Mpere ME, Kuma CMK, Ahmed O, Sakyi M, Bamfo-Ennin R, Donkor E, Malm F, Ampeh EM, Mettle DNA, Yemi B, Tei-Maya F, Amoako EK, Unlu E, Dzabeng F, Morang’a CM, Amuzu DSY, Awandare GA, Amambua-Ngwa A, Amenga-Etego LN. +24 moreeuropepmc +1 more sourceMaking the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine. [PDF]
Malar JMombo-Ngoma G, Ramharter M, Zoleko Manego R, Lell B, Bassat Q, Aide P, Maiga Ascofare O, Wells TNC, Djimde A, Ntoumi F, Kremsner PG. +10 moreeuropepmc +1 more source
